Results 31 to 40 of about 725,283 (343)

Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study. [PDF]

, 2018
Cardiovascular disease is a common comorbidity and cause of mortality in chronic obstructive pulmonary disease. A better understanding of mechanisms of cardiovascular risk in chronic obstructive pulmonary disease patients is needed to improve clinical ...
,, ,, Cheriyan, Joseph, Cockcroft, John R., Fisk, Marie, Forman, Julia R., Fuld, Jonathan, Gale, Nichola, McEniery, Carmel M., Mohan, Divya, Munnery, Margaret, Mäki-Petäjä, Kaisa, Polkey, Michael I., Tal-singer, Ruth, Wilkinson, Ian B., Woodcock-smith, Jean   +15 more
core   +4 more sources

Chronic obstructive pulmonary disease

BMJ, 2003
Three distinct disorders combine to produce chronic obstructive pulmonary disease (COPD): emphysema, peripheral airway disease or bronchospasm, and chronic bronchitis. Chronic obstructive pulmonary disease is defined as a disease state characterized by airflow limitation that is not fully reversible.
David, Price, Martin, Duerden
openaire   +5 more sources

Evaluation of Arterial Stiffness in Patients with Bronchial Asthma and Co-Existent Chronic Obstructive Pulmonary Disease

Galician Medical Journal, 2017
The objective of the research was to determine the characteristics of arterial stiffness and cardiovascular risk in patients with co-existence of asthma and chronic obstructive pulmonary disease. Materials and methods.
Kseniia Nazarenko
doaj   +1 more source

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD:a retrospective study of UK general practice [PDF]

, 2017
Initial use of inhaled corticosteroid therapy is common in patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) A or B chronic obstructive pulmonary disease, contrary to GOLD guidelines.
A Agusti, A Corrado, A Rossi, AG Kaplan, C Crim, CF Vogelmeier, D Price, D Price, E Herrett, H Magnussen, H Magnussen, H Watz, J Chalmers, JA Wedzicha, K Gruffydd-Jones, KM Beeh, LA García Rodríguez, M Miravitlles, MT Dransfield, N Roche, NC Barnes, NF Khan, PMA Calverley, RW Flynn, S Suissa, SS Jick, YK Loke   +26 more
core   +3 more sources

The Evaluation of Pulmonary Function Tests in Patients with Polycystic Ovary Syndrome [PDF]

Journal of Cardio-Thoracic Medicine, 2013
Introduction: Recently a relation between female sex hormones and severity of asthma symptoms has been proposed. As a common endocrine dysfunction, polycystic ovary syndrome (PCOS) could significantly influence the level of sex hormones in PCOS patients.
Davood Attaran, Sajad Ataei Azimi, Shahrzad M.Lari, Haleh Rokni, Morteza Taghavi, Mahdis Maraashi   +5 more
doaj  

Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review

International Journal of COPD, 2020
Background and Objectives Chronic obstructive pulmonary disease (COPD) affects over 250 million people globally, carrying a notable economic burden. This systematic literature review aimed to highlight the economic burden associated with moderate-to-very
I. Iheanacho, Shiyuan Zhang, D. King, M. Rizzo, A. Ismaila   +4 more
semanticscholar   +1 more source

Cardiovascular risk in patients with chronic obstructive pulmonary disease and metabolic syndrome [PDF]

Българска кардиология, 2023
Chronic obstructive pulmonary disease is a cause of morbidity and mortality worldwide. The presence of infl ammatory markers in circulation, sputum, and broncho-alveolar fl uid suggest systemic infl ammation is one of the potential mechanisms responsible
S. Nikolaeva, A. Angelov
doaj   +3 more sources

Inhaled corticosteroids versus long-acting beta -agonists for chronic obstructive pulmonary disease (Review). [PDF]

, 2011
Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler.
Agarwal, Anderson, Appleton, Barnes, Borgstrom, Borgstrom, Boyd, Burge, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverley, Calverly, Campbell, Campell, Cazzola, Cazzola, Celli, Celli, Celli, Celli, Corhay, Dahl, Della Cioppa, Egede, Ferguson, Ferguson, Gosman, Greefhorst, Halpin, Halpin, Halpin, Hanania, Hanania, Hanania, Higgins, Horstman, Hunjan, Hunjan, Hunjan, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Jones, Keene, Korsgaard, Kristufek, Lange, Lofdahl, Lofdahl, Lofdahl, Lofdahl, Lyseng-Williamson, Mahler, Mahler, Mahler, McGarvey, Milanowski, Nannini, Nannini, Nannini Luis, Nitschmann, Pauwels, Pauwels, Reynolds, Rodrigo, Rodrigo, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Spencer, Szafranski, Vestbo, Vestbo, Vestbo, Vestbo, Vestbo, Yang   +105 more
core   +2 more sources

Self management and symptom monitoring among older adults with chronic obstructive pulmonary disease [PDF]

, 2010
Aims. To describe self-management, symptom monitoring and the associated influences among older adults with chronic obstructive pulmonary disease. Background.
Chenoweth, L, Gallagher, R, Stein-Parbury, J, Warwick, M   +3 more
core   +1 more source

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany. [PDF]

, 2020
Introduction: With increasing availability of different treatments for chronic obstructive pulmonary disease (COPD), we sought to understand patient preferences for COPD treatment in the UK, USA, and Germany using a discrete choice experiment (DCE ...
Doll, HA, Gunsoy, NB, Ismaila, AS, Janssen, EM, Jones, PW, Lewis, HB, Llewellyn, S, Schroeder, M   +7 more
core   +1 more source